Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)
China
· Delayed Price · Currency is CNY
30.48
+0.18 (0.59%)
Jan 3, 2025, 3:04 PM CST
Shenzhen Salubris Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 610.61 | 580.07 | 637.09 | 533.73 | 60.86 | 715.2 | Upgrade
|
Depreciation & Amortization | 346.55 | 346.55 | 320.16 | 304.27 | 246.03 | 229.36 | Upgrade
|
Other Amortization | 32.57 | 32.57 | 28.87 | 20.16 | 17.92 | 17.27 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.48 | 0.48 | 0.18 | 1.3 | -0.21 | 1.11 | Upgrade
|
Asset Writedown & Restructuring Costs | 52.5 | 52.5 | 50.67 | 131.6 | 284.31 | 12.6 | Upgrade
|
Loss (Gain) From Sale of Investments | -20.21 | -20.21 | -44.14 | -134.24 | 26.78 | 31.2 | Upgrade
|
Provision & Write-off of Bad Debts | 2.49 | 2.49 | 3 | 0.44 | -8.29 | - | Upgrade
|
Other Operating Activities | 310.54 | 22.11 | 11.66 | 30.32 | 6.9 | -20.64 | Upgrade
|
Change in Accounts Receivable | 3.96 | 3.96 | -89.42 | 69.97 | 613.44 | 356.35 | Upgrade
|
Change in Inventory | 51.23 | 51.23 | -114.11 | -46.53 | 111.42 | 67.55 | Upgrade
|
Change in Accounts Payable | -219.18 | -219.18 | 41.69 | 277.54 | 52.29 | -48.52 | Upgrade
|
Change in Other Net Operating Assets | - | - | 104.38 | - | - | 152.93 | Upgrade
|
Operating Cash Flow | 1,158 | 839.44 | 970.8 | 1,185 | 1,374 | 1,507 | Upgrade
|
Operating Cash Flow Growth | 43.69% | -13.53% | -18.07% | -13.78% | -8.78% | 12.38% | Upgrade
|
Capital Expenditures | -597.18 | -671 | -598.96 | -482.5 | -642.47 | -457.19 | Upgrade
|
Sale of Property, Plant & Equipment | 0.59 | 0.58 | 0.59 | 1.59 | 0.89 | 0.15 | Upgrade
|
Investment in Securities | -1,238 | -730.75 | -682.06 | 93.53 | -225.04 | 222.93 | Upgrade
|
Other Investing Activities | 45.73 | 30.35 | 7.12 | 17.73 | 17.17 | 21.81 | Upgrade
|
Investing Cash Flow | -1,789 | -1,371 | -1,273 | -369.65 | -849.44 | -212.31 | Upgrade
|
Short-Term Debt Issued | - | 223.73 | 596.83 | 303.9 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 332 | 124 | Upgrade
|
Total Debt Issued | 59.66 | 223.73 | 596.83 | 303.9 | 332 | 124 | Upgrade
|
Short-Term Debt Repaid | - | -358.63 | -183.6 | -639.52 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -16.67 | -10.82 | -13.36 | -277.72 | -37.7 | Upgrade
|
Total Debt Repaid | -204.6 | -375.3 | -194.42 | -652.87 | -277.72 | -37.7 | Upgrade
|
Net Debt Issued (Repaid) | -144.94 | -151.56 | 402.41 | -348.97 | 54.28 | 86.3 | Upgrade
|
Issuance of Common Stock | - | - | - | 2,331 | - | - | Upgrade
|
Repurchase of Common Stock | - | - | -274.31 | -327.86 | -284.94 | - | Upgrade
|
Common Dividends Paid | -546.04 | -549.37 | -441.2 | -15.54 | -534.82 | -852.75 | Upgrade
|
Other Financing Activities | 598.11 | -4.57 | -88.41 | -90.45 | -1.38 | -63.13 | Upgrade
|
Financing Cash Flow | -92.87 | -705.5 | -401.5 | 1,548 | -766.86 | -829.59 | Upgrade
|
Foreign Exchange Rate Adjustments | -10.38 | 4.07 | 32.96 | -6.77 | -4.84 | 2.08 | Upgrade
|
Net Cash Flow | -733.38 | -1,233 | -671.04 | 2,357 | -246.81 | 466.83 | Upgrade
|
Free Cash Flow | 561.22 | 168.44 | 371.84 | 702.48 | 731.86 | 1,049 | Upgrade
|
Free Cash Flow Growth | 362.48% | -54.70% | -47.07% | -4.02% | -30.26% | 4.13% | Upgrade
|
Free Cash Flow Margin | 14.35% | 5.01% | 10.68% | 22.97% | 26.72% | 23.48% | Upgrade
|
Free Cash Flow Per Share | 0.51 | 0.15 | 0.34 | 0.66 | 0.72 | 1.00 | Upgrade
|
Cash Income Tax Paid | 432.02 | 406.42 | 404.25 | 324.11 | 295.41 | 850.92 | Upgrade
|
Levered Free Cash Flow | 214.22 | -517.28 | 494.8 | 240.9 | 723.09 | 1,252 | Upgrade
|
Unlevered Free Cash Flow | 224.03 | -506.42 | 502.64 | 247.48 | 734.07 | 1,262 | Upgrade
|
Change in Net Working Capital | -44.96 | 579.5 | -399.08 | -90.37 | -921.15 | -957.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.